Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion type Assertion NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_head.
- NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion description "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_provenance.
- NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion evidence source_evidence_literature NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_provenance.
- NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion SIO_000772 24139215 NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_provenance.
- NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion wasDerivedFrom befree-20150227 NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_provenance.
- NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion wasGeneratedBy ECO_0000203 NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_provenance.